Provided by Tiger Fintech (Singapore) Pte. Ltd.

2Seventy Bio Inc

4.99
+0.01000.20%
Volume:287.06K
Turnover:1.43M
Market Cap:265.61M
PE:-4.55
High:4.99
Open:4.98
Low:4.98
Close:4.98
Loading ...

Company Profile

Company Name:
2Seventy Bio Inc
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
65
Office Location:
60 Binney Street,Cambridge,Massachusetts,United States
Zip Code:
02142
Fax:
- -
Introduction:
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Directors

Name
Position
Daniel S. Lynch
Chairman and Director
Nick Leschly
President, Chief Executive Officer and Director
Denice Torres
Director
Marcela Maus
Director
Ramy Ibrahim
Director
Sarah Glickman
Director
Wei Lin
Director

Shareholders

Name
Position
Nick Leschly
President, Chief Executive Officer and Director
William D. Baird, III
Chief Financial Officer
Philip Gregory
Chief Scientific Officer